上海医药：关于多西环素胶囊获得美国FDA批准文号的公告

Core Viewpoint - Shanghai Pharmaceuticals announced the approval of its abbreviated new drug application (ANDA) for doxycycline capsules by the U.S. Food and Drug Administration (FDA) [2] Company Summary - Shanghai Pharmaceuticals' subsidiary, Changzhou Pharmaceutical Factory, received notification from the FDA regarding the approval of its ANDA for doxycycline capsules [2]